Sanguisorba officinalis L. suppresses non-small cell lung cancer via downregulating the PI3K/AKT/mTOR signaling pathway based on network pharmacology and experimental investigation

• المؤلفون الرئيسيون: Hong Li (مؤلف), Jing Lin (مؤلف), Fei Yang (مؤلف), Junzhu Deng (مؤلف), Jia Lai (مؤلف), Jing Zeng (مؤلف), Wenjun Zou (مؤلف), Nan Jiang (مؤلف), Qianqian Huang (مؤلف), Hua Li (مؤلف), Jian Liu (مؤلف), Mao Li (مؤلف), Zhirong Zhong (مؤلف), Jianming Wu (مؤلف)
• التنسيق: كتاب
• منشور في: Frontiers Media S.A., 2022-11-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Background: Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. Sanguisorba officinalis L. (SOL), a traditional Chinese herbal medicine called Diyu, has been shown to have potent antitumor effects. However, the role of SOL in suppressing NSCLC remains unknown.Methods: Network...